Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Human HRAS ELISA Kit (ab267797)

Price and availability

354 472 ₸

Availability

Order now and get it on Wednesday March 03, 2021

Human HRAS ELISA Kit (ab267797)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • One-wash 90 minute protocol
  • Sensitivity: 27 pg/ml
  • Range: 125 pg/ml - 8000 pg/ml
  • Sample type: Cell Lysate
  • Detection method: Colorimetric
  • Assay type: Sandwich (quantitative)
  • Reacts with: Human

You may also be interested in

Product image
Anti-SDHA antibody [EPR9043(B)] (ab137040)
Cyanine5.5 azide (DMSO solution), Far red/near infra- red dye (ab235026)
Product image
Anti-Carbonic Anhydrase 9/CA9 antibody [SP106] (ab105226)
Product image
Anti-AS3 antibody (ab153895)

Overview

  • Product name

    Human HRAS ELISA Kit
    See all GTPase HRAS kits
  • Detection method

    Colorimetric
  • Precision

    Intra-assay
    Sample n Mean SD CV%
    Extract 8 3.4%
    Inter-assay
    Sample n Mean SD CV%
    Extract 3 1.8%
  • Sample type

    Cell Lysate
  • Assay type

    Sandwich (quantitative)
  • Sensitivity

    27 pg/ml
  • Range

    125 pg/ml - 8000 pg/ml
  • Recovery

    Sample specific recovery
    Sample type Average % Range
    Cell Lysate 94 89% - 103%
  • Assay time

    1h 30m
  • Assay duration

    One step assay
  • Species reactivity

    Reacts with: Human
  • Product overview

    Human HRAS ELISA Kit (ab267797) is a single-wash 90 min sandwich ELISA designed for the quantitative measurement of HRAS protein in cell lysate. It uses our proprietary SimpleStep ELISA® technology. Quantitate Human HRAS with 27 pg/ml sensitivity.


    SimpleStep ELISA® technology employs capture antibodies conjugated to an affinity tag that is recognized by the monoclonal antibody used to coat our SimpleStep ELISA® plates. This approach to sandwich ELISA allows the formation of the antibody-analyte sandwich complex in a single step, significantly reducing assay time. See the SimpleStep ELISA® protocol summary in the image section for further details. Our SimpleStep ELISA® technology provides several benefits:


            - Single-wash protocol reduces assay time to 90 minutes or less
            - High sensitivity, specificity and reproducibility from superior antibodies
            - Fully validated in biological samples
            - 96-wells plate breakable into 12 x 8 wells strips


    A 384-well SimpleStep ELISA® microplate (ab203359) is available to use as an alternative to the 96-well microplate provided with SimpleStep ELISA® kits.

  • Notes

    HRAS, is a GTPase and an integral cell signaling molecule responsible for propagating kinase cascades in response to various extracellular stimuli. Given its importance in cell signaling cascades, aberrant HRAS function leads to a host of cancers. The antibodies for this kit were raised against a full-length human protein which is homologous throughout Mammalia. As such, this kit is expected to react with many species.

    Abcam has not and does not intend to apply for the REACH Authorisation of customers’ uses of products that contain European Authorisation list (Annex XIV) substances.
    It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

  • Platform

    Pre-coated microplate (12 x 8 well strips)

Properties

  • Storage instructions

    Store at +4°C. Please refer to protocols.
  • Components 1 x 96 tests
     HRAS Lyophilized Recombinant Protein 2 vials
    10X HRAS Capture Antibody 1 x 600µl
    10X HRAS Detector Antibody 1 x 600µl
    10X Wash Buffer PT (ab206977) 1 x 20ml
    5X Cell Extraction Buffer PTR (ab193970) 1 x 10ml
    Antibody Diluent 4BI 1 x 6ml
    Plate Seals 1 unit
    Sample Diluent NS (ab193972) 1 x 12ml
    SimpleStep Pre-Coated 96-Well Microplate (ab206978) 1 unit
    Stop Solution 1 x 12ml
    TMB Development Solution 1 x 12ml
  • Research areas

    • Cell Biology
    • Apoptosis
    • Intracellular
    • Associated Proteins
    • Signal Transduction
    • Signaling Pathway
    • G Protein Signaling
    • Small G Proteins
    • Ras Family
    • Cell Biology
    • Cell Cycle
    • Cell differentiation
    • Epigenetics and Nuclear Signaling
    • Transcription
    • Cancer susceptibility
    • Proto-oncogenes
    • Cancer
    • Signal transduction
    • G protein signaling
    • Small G proteins
    • Ras family
  • Function

    Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
  • Involvement in disease

    Defects in HRAS are the cause of faciocutaneoskeletal syndrome (FCSS) [MIM:218040]. A rare condition characterized by prenatally increased growth, postnatal growth deficiency, mental retardation, distinctive facial appearance, cardiovascular abnormalities (typically pulmonic stenosis, hypertrophic cardiomyopathy and/or atrial tachycardia), tumor predisposition, skin and musculoskeletal abnormalities.
    Defects in HRAS are the cause of congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040]. CMEMS is a variant of Costello syndrome.
    Defects in HRAS may be a cause of susceptibility to Hurthle cell thyroid carcinoma (HCTC) [MIM:607464]. Hurthle cell thyroid carcinoma accounts for approximately 3% of all thyroid cancers. Although they are classified as variants of follicular neoplasms, they are more often multifocal and somewhat more aggressive and are less likely to take up iodine than are other follicular neoplasms.
    Note=Mutations which change positions 12, 13 or 61 activate the potential of HRAS to transform cultured cells and are implicated in a variety of human tumors.
    Defects in HRAS are a cause of susceptibility to bladder cancer (BLC) [MIM:109800]. A malignancy originating in tissues of the urinary bladder. It often presents with multiple tumors appearing at different times and at different sites in the bladder. Most bladder cancers are transitional cell carcinomas. They begin in cells that normally make up the inner lining of the bladder. Other types of bladder cancer include squamous cell carcinoma (cancer that begins in thin, flat cells) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). Bladder cancer is a complex disorder with both genetic and environmental influences.
    Note=Defects in HRAS are the cause of oral squamous cell carcinoma (OSCC).
  • Sequence similarities

    Belongs to the small GTPase superfamily. Ras family.
  • Post-translational
    modifications

    Palmitoylated by the ZDHHC9-GOLGA7 complex. A continuous cycle of de- and re-palmitoylation regulates rapid exchange between plasma membrane and Golgi.
    S-nitrosylated; critical for redox regulation. Important for stimulating guanine nucleotide exchange. No structural perturbation on nitrosylation.
  • Cellular localization

    Cell membrane. Golgi apparatus membrane. The active GTP-bound form is localized most strongly to membranes than the inactive GDP-bound form (By similarity). Shuttles between the plasma membrane and the Golgi apparatus.
  • Target information above from: UniProt accession P01112 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Alternative names

    • C BAS/HAS
    • c H ras
    • C HA RAS1
    • c has/bas p21 protein
    • c ras Ki 2 activated oncogene
    • c-H-ras
    • CTLO
    • GTP and GDP binding peptide B
    • GTPase HRas, N-terminally processed
    • H Ras 1
    • H RASIDX
    • H-Ras-1
    • Ha Ras
    • Ha Ras1 proto oncoprotein
    • Ha-Ras
    • HAMSV
    • Harvey rat sarcoma viral oncogene homolog
    • Harvey rat sarcoma viral oncoprotein
    • HRAS
    • HRAS1
    • K ras
    • N ras
    • p19 H RasIDX protein
    • p21ras
    • Ras family small GTP binding protein H Ras
    • RASH_HUMAN
    • RASH1
    • Transformation gene oncogene HAMSV
    • Transforming protein p21
    • v Ha ras Harvey rat sarcoma viral oncogene homolog
    • VH Ras
    • vHa RAS
    see all
  • Database links

    • Entrez Gene: 3265 Human
    • Omim: 190020 Human
    • SwissProt: P01112 Human
    • Unigene: 37003 Human

    Images

    • SimpleStep ELISA Protocol Diagram
      SimpleStep ELISA Protocol Diagram

      SimpleStep ELISA technology allows the formation of the antibody-antigen complex in one single step, reducing assay time to 90 minutes. Add samples or standards and antibody mix to wells all at once, incubate, wash, and add your final substrate. See protocol for a detailed step-by-step guide.

    • Example of HRAS standard curve in 1X Cell Extraction Buffer PTR.
      Example of HRAS standard curve in 1X Cell Extraction Buffer PTR.

      The HRAS standard curve was prepared as described in Section 10. Raw data values are shown in the table. Background-subtracted data values (mean +/- SD) are graphed.

    • Interpolated concentrations of native HRAS in MCF-7 cell extracts based on a 1,500 µg/mL extract load.
      Interpolated concentrations of native HRAS in MCF-7 cell extracts based on a 1,500 µg/mL extract load.

      The concentrations of HRAS were measured in duplicate and interpolated from the HRAS standard curve and corrected for sample dilution. The interpolated dilution factor corrected values are plotted (mean +/- SD, n=2). The mean HRAS concentration was determined to be 4018.03 pg/mL.

       

       

    • Sandwich ELISA - Human HRAS ELISA Kit (ab267797)
      Sandwich ELISA - Human HRAS ELISA Kit (ab267797)
      To learn more about the advantages of recombinant antibodies see here.

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
    For licensing inquiries, please contact partnerships@abcam.com

    Alternative products to Human HRAS ELISA Kit (ab267797)

    •  
    • Product image

      Human HRAS Antibody Pair - BSA and Azide free (ab270354)

      Applications:

    Clear all

    Recently viewed products

    •  
    • Product image

      Anti-Lin28A antibody [EPR4640] (ab124765)

    •  
    • Product image

      Anti-SOX1 antibody [EPR23041-60] (ab242125)

    •  
    • Product image

      Anti-USP16 antibody [EPR20914-47] (ab236628)

    •  
    • Product image

      Anti-IL-7 antibody [EPR19464-214] (ab222570)

    •  
    • Product image

      Anti-Mesothelin antibody [EPR19025-45] (ab222662)

    •  
    • Product image

      Anti-USP30 antibody [CL4438] (ab219969)

    Get resources and offers direct to your inbox Sign up
    © 2021 Astana Biomed Group LLP. All rights reserved.